Publications
2009
Experimental immunotherapeutic approaches for atherosclerosis.
Amir S,
Binder CJ.
Clin Immunol, Epub 2009 Aug 8.
2008
Plasma interleukin – 5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis.
Sämpi M,
Ukkola O,
Päivänsalo M,
Kesäniemi YA,
Binder CJ,
Hörkkö S.
J Am Coll Cardiol. 2008, Oct 21;52(17):1370–8.
2008
Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.
Imai Y,
Kuba K,
Neely GG,
Yaghubian-Malhami R,
Perkmann T,
van Loo G,
Ermolaeva M,
Veldhuizen R,
Leung YH,
Wang H,
Liu H,
Sun Y,
Pasparakis M,
Kopf M,
Mech C,
Bavari S,
Peiris JS,
Slutsky AS,
Akira S,
Hultqvist M,
Holmdahl R,
Nicholls J,
Jiang C,
Binder CJ,
Penninger JM.
Cell. 2008, Apr 18;133(2):235–49.
2008
Oxidation-specific epitopes are important targets of innate immunity.
Chou MY,
Hartvigsen K,
Hansen LF,
Fogelstrand L,
Shaw PX,
Boullier A,
Binder CJ,
Witztum JL.
J Intern Med. 2008, May;263(5):479–88. Review.
2008
A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice.
Bro S,
Flyvbjerg A,
Binder CJ,
Bang CA,
Denner L,
Olgaard K,
Nielsen LB.
Atherosclerosis. 2008, Dec;201(2):274–80.
2008
Natural antibodies in murine atherosclerosis.
Binder CJ,
Chou MY,
Fogelstrand L,
Hartvigsen K,
Shaw PX,
Boullier A,
Witztum JL.
Curr Drug Targets. 2008, Mar;9(3):190–5. Review.
2008
A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma.
Bergmark C,
Dewan A,
Orsoni A,
Merki E,
Miller ER,
Shin MJ,
Binder CJ,
Hörkkö S,
Krauss RM,
Chapman MJ,
Witztum JL,
Tsimikas S.
J Lipid Res. 2008, Oct;49(10):2230–9.
2007
A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome.
Hartvigsen K,
Binder CJ,
Hansen LF,
Rafia A,
Juliano J,
et al.
Arterioscl Thromb Vasc Biol. 2007, 27(4):878–85.
2007
Inhibition of the Renin-Angiotensin System Abolishes the Proatherogenic Effect of Uremia in Apolipoprotein E-Deficient Mice.
Bro S,
Binder CJ,
Witztum JL,
Olgaard K,
Nielsen LB.
Arterioscl Thromb Vasc Biol. 2007, 27(5):1080–6.
2007
Promise of immune modulation to inhibit atherogenesis.
Binder CJ,
Hartvigsen K,
Witztum JL.
J Am Coll Cardiol. 2007, 50(6):547–50.
